Enzalutamide monotherapy: Phase II study results in patients with hormone-naive prostate cancer.
Bertrand Tombal
Consultant or Advisory Role - Astellas Pharma
Honoraria - Astellas Pharma; Astellas Pharma; Astellas Pharma; Medivation
Michael Borre
No relevant relationships to disclose
Per Rathenborg
No relevant relationships to disclose
Patrick Werbrouck
No relevant relationships to disclose
Axel Heidenreich
Honoraria - Astellas Pharma
Peter Iversen
Honoraria - Astellas Pharma
Edwina S. Baskin-Bey
Employment or Leadership Position - Astellas Pharma
Frank Perabo
Employment or Leadership Position - Astellas Pharma
De Phung
Employment or Leadership Position - Astellas Pharma
Matthew Raymond Smith
Honoraria - Astellas Pharma; Medivation